Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

[1]  Z. Cai,et al.  Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. , 2016, Cancer letters.

[2]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[3]  Z. Cai,et al.  shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells , 2016, Oncotarget.

[4]  X. Zu,et al.  Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy , 2016, Journal of experimental & clinical cancer research : CR.

[5]  Maite Huarte.  The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[6]  Z. Cai,et al.  Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells , 2015, Oncotarget.

[7]  D. Gallie.  Faculty Opinions recommendation of The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. , 2015 .

[8]  James J. Collins,et al.  Chromatin regulation at the frontier of synthetic biology , 2015, Nature Reviews Genetics.

[9]  Kai Wang,et al.  Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma , 2015, Journal of experimental & clinical cancer research : CR.

[10]  Arsen O. Batagov,et al.  HOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptome , 2014, BMC Genomics.

[11]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[12]  D. Largaespada,et al.  PVT1 dependence in cancer with MYC copy-number increase , 2014, Nature.

[13]  F. Liu,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[14]  F. Lienert,et al.  Synthetic biology in mammalian cells: next generation research tools and therapeutics , 2014, Nature Reviews Molecular Cell Biology.

[15]  Piroon Jenjaroenpun,et al.  Role of genomic architecture in the expression dynamics of long noncoding RNAs during differentiation of human neuroblastoma cells , 2013, BMC Systems Biology.

[16]  S. Goodison,et al.  Urinary biomarkers of bladder cancer: an update and future perspectives. , 2013, Biomarkers in medicine.

[17]  P. Darcy,et al.  Gene-engineered T cells for cancer therapy , 2013, Nature Reviews Cancer.

[18]  M. Brausi.  Primary prevention and early detection of bladder cancer: two main goals for urologists. , 2013, European urology.

[19]  Michel Sadelain,et al.  Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells , 2012, Nature Biotechnology.

[20]  Ahmad S. Khalil,et al.  A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions , 2012, Cell.

[21]  Raj Persad,et al.  A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. , 2011, The Journal of urology.

[22]  Uri Laserson,et al.  Autoantigen discovery with a synthetic human peptidome. , 2011, Nature biotechnology.

[23]  G. Crabtree,et al.  Engineering the ABA Plant Stress Pathway for Regulation of Induced Proximity , 2011, Science Signaling.

[24]  Saraswati Sukumar,et al.  The Hox genes and their roles in oncogenesis , 2010, Nature Reviews Cancer.

[25]  Ahmad S. Khalil,et al.  Synthetic biology: applications come of age , 2010, Nature Reviews Genetics.

[26]  P. Poltronieri,et al.  Non-protein coding RNA biomarkers and differential expression in cancers: a review , 2008, Journal of experimental & clinical cancer research : CR.

[27]  L. Koniaris,et al.  Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease. , 2008, The Journal of urology.

[28]  B. Weimer,et al.  Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression , 2007, Clinical & Experimental Metastasis.

[29]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[30]  Takayuki Kosaka,et al.  Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  L. Mir,et al.  Coelectrotransfer to skeletal muscle of three plasmids coding for antiangiogenic factors and regulatory factors of the tetracycline-inducible system: tightly regulated expression, inhibition of transplanted tumor growth, and antimetastatic effect. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  J. McCubrey,et al.  Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy , 2003, Leukemia.

[33]  F. Burkhard,et al.  Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Michael J. Terry,et al.  HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas , 2002, Oncogene.

[35]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  M. Green,et al.  Controlling gene expression in living cells through small molecule-RNA interactions. , 1998, Science.

[37]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.